VIPS Q1 2026 Earnings EPS Misses Estimates Shares Dip Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain SNAP Q1 2026 Earnings EPS Beat Driven by Cost Discipline Amidst Mixed Revenue Trends PDD Q4 2025 Earnings EPS Misses Estimates by 156 Shares Decline 33 ORI Q1 2026 Earnings Earnings Miss by 15 as EPS Falls Short of Estimates STLD Q1 2026 Earnings Earnings Miss Estimates Despite Strong Operational Execution